Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K
Experimental RNAi02:15

Experimental RNAi

7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K
RNA Interference01:23

RNA Interference

27.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.8K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

4.2K
4.2K
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

5.4K
5.4K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

10.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: A generalizable approach for programming protease-responsive conformationally inhibited artificial transcriptional factors.

Nature communications·2026
Same author

Generalized Biosensing and Signaling Reprogramming Using Circular RNA-Protein Circuit-Mediated Cargo Release.

Analytical chemistry·2026
Same author

Synergistic Remodeling of Tumor Immune Microenvironment via a DNA Nanodevice Integrating STING Activation and Lysosome-Targeted PD-L1 Degradation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Light-Inducible Bispecific DNAzymes Reveal Mitochondrial Fe<sup>2+</sup>/Fe<sup>3+</sup> Dynamics During Ferroptosis.

Angewandte Chemie (International ed. in English)·2026
Same author

Ketal-Bridged Rhodamines as a New Scaffold for Near-Infrared Chemigenetic Indicators with Enhanced Fluorogenicity.

Journal of the American Chemical Society·2026
Same author

Bile acid metabolomics reveals distinct immunometabolic niches and enables accurate diagnosis of AQP4-IgG-seronegative NMOSD.

Frontiers in immunology·2026

Related Experiment Video

Updated: Jan 14, 2026

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
11:53

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

Published on: July 21, 2017

7.7K

Chemically inducible antisense oligonucleotides for cell-specific gene silencing.

Zhen Xun1, Yang Hai1, Li-Juan Tang1

  • 1State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Hunan University Changsha 410082 China tomwu@hnu.edu.cn.

RSC Chemical Biology
|October 23, 2025
PubMed
Summary

Chemically inducible antisense oligonucleotides (ASOs) are activated by hydrogen peroxide (H2O2) for tumor-specific gene silencing. This novel approach enables precise gene therapy with reduced side effects in normal cells.

More Related Videos

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.8K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.9K

Related Experiment Videos

Last Updated: Jan 14, 2026

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
11:53

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

Published on: July 21, 2017

7.7K
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.8K
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

7.9K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Therapeutic Development

Background:

  • Antisense oligonucleotides (ASOs) offer precise gene silencing for therapeutic applications.
  • Achieving cell-specific ASO function is crucial to minimize off-target effects and enhance safety.

Purpose of the Study:

  • To develop a novel class of chemically inducible ASOs (iASOs) for tumor-cell-selective gene silencing.
  • To establish a platform for conditional gene regulation using H2O2-triggered activation.

Main Methods:

  • Post-synthetic incorporation of phenylboronic acid (BO) caging groups into ASO backbones.
  • Development of iASOs activated by hydrogen peroxide (H2O2)-triggered removal of BO groups.
  • Utilizing an EGFP reporter system and targeting the endogenous Bcl2 gene to assess knockdown efficiency and cell death induction.

Main Results:

  • Optimal BO-modified iASOs showed minimal gene silencing in normal cells but achieved >80% knockdown in tumor cells.
  • Demonstrated successful targeting of the Bcl2 gene, leading to controlled gene silencing and induced cell death.
  • Established a simple and effective platform for conditional gene regulation.

Conclusions:

  • Developed a novel class of chemically inducible ASOs (iASOs) for targeted gene therapy.
  • H2O2-triggered activation of BO-caged ASOs enables tumor-cell-selective gene silencing.
  • This platform facilitates the development of safer and more effective cell-specific ASO therapeutics.